đź“Š Evidence-Based Reference
hemoglide series and hemoglide star series xk long-term hemodialysis catheters
C.R. Bard
Summary: The Hemoglide series by C.R. Bard are long-term hemodialysis catheters. They are primarily used for vascular access in dialysis patients. Key evidence findings are not available from the provided studies.
FDA Clearance Information
Pathway 510K
Number K051748 ↗
Decision Date August 12, 2005
Product Code MSD
Device Class Class 2
Evidence 0 studies
The Hemoglide series catheters were cleared by the FDA via the 510(k) pathway on August 12, 2005. They are manufactured by C.R. Bard and classified as Class 2 devices under product code MSD.
What It Is
The Hemoglide series are hemodialysis catheters designed for long-term vascular access in patients requiring dialysis. These devices facilitate efficient blood flow and are intended for use in clinical settings where long-term dialysis access is necessary.
Clinical Applications
These catheters are commonly used in patients with chronic kidney disease who require regular hemodialysis. They provide a reliable means of vascular access, which is crucial for effective dialysis treatment.
Evidence Summary
The available literature includes 9 studies, though none directly address the Hemoglide series. The studies range from 2021 to 2024 and cover various unrelated topics, indicating a lack of specific evidence for these devices.
Reported Outcomes
Published studies report no specific efficacy findings related to the Hemoglide series catheters. The evidence provided does not include direct outcomes from clinical use of these devices.
Safety Profile
Reported complications include no specific safety data related to the Hemoglide series catheters. The provided studies do not offer insights into adverse events or complications associated with these devices.
Evidence Limitations
There is a significant gap in direct evidence regarding the Hemoglide series catheters. The studies provided do not focus on these devices, highlighting a need for targeted research to evaluate their clinical efficacy and safety.
Frequently Asked Questions
What are the clinical indications for hemoglide catheters?
The Hemoglide series catheters are indicated for long-term vascular access in patients requiring hemodialysis.
What outcomes have been reported in clinical studies?
Specific findings from evidence are not available for the Hemoglide series catheters in the provided studies.
What complications have been reported?
Safety data from evidence is not available for the Hemoglide series catheters in the provided studies.
Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference.
It does not constitute medical advice, product endorsement, or a recommendation for clinical use.
Always consult manufacturer documentation and clinical judgment for patient care decisions.